MarginsXMarginsX
Home › Markets › Health Care › NXL

Nexalin Technology Inc. (NXL)

NXL trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.56
+2.30% on the day
Market cap
$1.9M
Nano cap
Revenue · 2025
$302K
+78.8% on 2024
Net income · 2025
-$8.2M
-2725.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1527352/000182912626002673/0001829126-26-002673-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerNXL on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year2022
SEC CIK0001527352
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$302K
Net income-$8.2M
Operating income-$8.4M
Net margin-2725.8%
Operating margin-2781.7%
Revenue growth+78.8%
Cash$655K
Total assets$4.6M
P/E (computed)Net income was not positive
P/S (computed)6.4×

Warning signs

Cash runway
1.5 months
$793K cash at September 30, 2026
Share count, 1 year
+98.9%
2025-11-13 to 2026-11-10 · +398.8% over 3 years
Going-concern doubt
Yes
10-Q filed November 12, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-11-12
Cash and burn$793K cash; operating cash flow -$1.6M a quarter.Report 2026-09-30
Shares outstanding1,236,560 (2026-11-10); 18,651,939 a year earlier; 7,436,562 three years earlier. 1y figure adjusted for split (1-for-30 overall); 3y figure adjusted for split (1-for-30 overall).Cover page 2026-11-10
Reverse splits, 3 years1; latest 1-for-30 on 2026-08-31Source 2026-08-31
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-08-20
Exchange deficiency notices, 12 months4 (8-K item 3.01)8-K 2026-09-28
Delisting25-NSE filed25-NSE 2025-09-19
AuditorCBIZ CPAs P.C., Marlton, New Jersey, United States; changed auditors 1 time in 24 months8-K 4.01 2025-04-17
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$78K-$2.7M-$1.6M$793K$953K$277K10-Q 2026-11-12
Q2 2026
2026-06-30
$12K-$2.2M-$1.8M$1.0MNo debt tags$217K10-Q 2026-08-12
Q1 2026
2026-03-31
$15K-$2.1M-$1.7M$1.2MNo debt tags$276K10-Q 2026-05-08
Q4 2025
2025-12-31
$172K-$2.4M-$1.1M$655KNo debt tags$302K10-K 2026-03-25
Q3 2025
2025-09-30
$18K-$2.3M-$1.5M$590KNo debt tags$157K10-Q 2026-11-12
Q2 2025
2025-06-30
$71K-$1.6M-$917K$431KNo debt tags$175K10-Q 2026-08-12
Q1 2025
2025-03-31
$41K-$2.0M-$1.4M$622KNo debt tags$131K10-Q 2026-05-08
Q4 2024
2024-12-31
$27K-$2.8M-$1.1M$574KNo debt tags$169K10-K 2026-03-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-1/A2026-10-08
Latest annual report10-K2026-03-25
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-10-01
Latest proxyDEF 14A2026-11-06

Source: SEC EDGAR submissions feed, 207 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.7%
1 month-43.9%
3 months-85.9%
Year to date-91.2%
1 year-95.8%
From 52-week high-95.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
NUWENuwellis Inc.$4.48-8.57%$2.4M
VBIOValion Bio Inc.$0.5290+0.84%$1.1M
NDRAENDRA Life Sciences Inc.$4.42-1.78%$6.6M
IRIXIRIDEX Corporation$0.6878-0.32%$12.1M
ITOCiTonic Holdings Ltd$1.88-5.05%$13.8M
QTIQT Imaging Holdings Inc.$1.80-4.26%$26.4M
ECORelectroCore Inc.$4.84-7.81%$44.7M
POCIPrecision Optics Corporation Inc.$4.97-4.97%$54.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier